A global life sciences measurement and tools company with cutting-edge capabilities in genomic analysis and quality assurance wishes to identify novel approaches for scalable synthesis of oligonucleotides.
Healx, an AI-powered, patient-inspired, biotech company, is seeking rare disease therapeutic opportunities from academic, patient groups or (early-stage) biotechs. Healx, along with their partners, aim to quickly turn research into... read more →
Chiesi Global Rare Diseases is seeking research proposals for new technologies from academic medical centres, universities, and research institutions globally. Their objective is to award funds to validate early‐stage projects... read more →